Private Capital Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-5,000
| Closed | -$377K | – | 77 |
|
|
2025
Q3 | $377K | Hold |
5,000
| – | – | 0.04% | 62 |
|
|
2025
Q2 | $345K | Hold |
5,000
| – | – | 0.04% | 65 |
|
|
2025
Q1 | $339K | Hold |
5,000
| – | – | 0.04% | 57 |
|
|
2024
Q4 | $224K | Hold |
5,000
| – | – | 0.03% | 66 |
|
|
2024
Q3 | $314K | Hold |
5,000
| – | – | 0.03% | 61 |
|
|
2024
Q2 | $295K | Hold |
5,000
| – | – | 0.03% | 67 |
|
|
2024
Q1 | $399K | Hold |
5,000
| – | – | 0.05% | 62 |
|
|
2023
Q4 | $395K | Sell |
5,000
-3,450
| -41% | -$246K | 0.06% | 57 |
|
|
2023
Q3 | $583K | Hold |
8,450
| – | – | 0.09% | 54 |
|
|
2023
Q2 | $584K | Hold |
8,450
| – | – | 0.1% | 51 |
|
|
2023
Q1 | $628K | Hold |
8,450
| – | – | 0.12% | 52 |
|
|
2022
Q4 | $787K | Hold |
8,450
| – | – | 0.13% | 47 |
|
|
2022
Q3 | $806K | Hold |
8,450
| – | – | 0.14% | 50 |
|
|
2022
Q2 | $783K | Hold |
8,450
| – | – | 0.13% | 51 |
|
|
2022
Q1 | $855K | Hold |
8,450
| – | – | 0.12% | 64 |
|
|
2021
Q4 | $872K | Hold |
8,450
| – | – | 0.14% | 49 |
|
|
2021
Q3 | $717K | Hold |
8,450
| – | – | 0.12% | 55 |
|
|
2021
Q2 | $705K | Hold |
8,450
| – | – | 0.12% | 57 |
|
|
2021
Q1 | $636K | Hold |
8,450
| – | – | 0.12% | 64 |
|
|
2020
Q4 | $577K | Hold |
8,450
| – | – | 0.12% | 61 |
|
|
2020
Q3 | $493K | Hold |
8,450
| – | – | 0.11% | 66 |
|
|
2020
Q2 | $549K | Hold |
8,450
| – | – | 0.14% | 55 |
|
|
2020
Q1 | $501K | Hold |
8,450
| – | – | 0.16% | 55 |
|
|
2019
Q4 | $628K | Hold |
8,450
| – | – | 0.15% | 56 |
|
|
2019
Q3 | $533K | Hold |
8,450
| – | – | 0.15% | 61 |
|
|
2019
Q2 | $460K | Hold |
8,450
| – | – | 0.13% | 69 |
|
|
2019
Q1 | $456K | Hold |
8,450
| – | – | 0.14% | 70 |
|
|
2018
Q4 | $554K | Hold |
8,450
| – | – | 0.2% | 57 |
|
|
2018
Q3 | $665K | Hold |
8,450
| – | – | 0.18% | 64 |
|
|
2018
Q2 | $544K | Hold |
8,450
| – | – | 0.17% | 67 |
|
|
2018
Q1 | $526K | Hold |
8,450
| – | – | 0.18% | 72 |
|
|
2017
Q4 | $613K | Sell |
8,450
-325
| -4% | -$23.6K | 0.21% | 71 |
|
|
2017
Q3 | $714K | Hold |
8,775
| – | – | 0.24% | 63 |
|
|
2017
Q2 | $706K | Buy |
8,775
+325
| +4% | +$25.7K | 0.23% | 79 |
|
|
2017
Q1 | $663K | Hold |
8,450
| – | – | 0.22% | 82 |
|
|
2016
Q4 | $667K | Hold |
8,450
| – | – | 0.23% | 75 |
|
|
2016
Q3 | $752K | Hold |
8,450
| – | – | 0.27% | 69 |
|
|
2016
Q2 | $809K | Hold |
8,450
| – | – | 0.31% | 62 |
|
|
2016
Q1 | $877K | Hold |
8,450
| – | – | 0.39% | 59 |
|
|
2015
Q4 | $826K | Hold |
8,450
| – | – | 0.36% | 62 |
|
|
2015
Q3 | $815K | Hold |
8,450
| – | – | 0.34% | 69 |
|
|
2015
Q2 | $886K | Hold |
8,450
| – | – | 0.29% | 79 |
|
|
2015
Q1 | $872K | Hold |
8,450
| – | – | 0.32% | 69 |
|
|
2014
Q4 | $814K | Hold |
8,450
| – | – | 0.31% | 70 |
|
|
2014
Q3 | $673K | Hold |
8,450
| – | – | 0.22% | 83 |
|
|
2014
Q2 | $637K | Hold |
8,450
| – | – | 0.21% | 80 |
|
|
2014
Q1 | $633K | Hold |
8,450
| – | – | 0.24% | 69 |
|
|
2013
Q4 | $605K | Hold |
8,450
| – | – | 0.21% | 74 |
|
|
2013
Q3 | $480K | Hold |
8,450
| – | – | 0.17% | 81 |
|
|
2013
Q2 | $483K | Buy |
+8,450
| New | +$490K | 0.18% | 83 |
|
Other funds holding CVS
Private Capital Advisors's CVS Position: Q4 2025 in Review
Private Capital Advisors sold out of CVS Health (CVS) in Q4 2025, closing a stake of 5,000 shares — an estimated $377K sold.
Private Capital Advisors first reported a position in CVS in Q2 2013 and held it in 50 quarters. The position peaked at $886K in Q2 2015. 1,948 funds tracked by Wall St. Rank hold CVS as of Q4 2025.
- Private Capital Advisors reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
- Private Capital Advisors sold 5,000 CVS Health shares in Q4 2025, an estimated $377K.
- Private Capital Advisors first reported a position in CVS Health in Q2 2013 and held it in 50 quarters.
- Private Capital Advisors's CVS Health position peaked at $886K in Q2 2015.
- 1,948 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.
Based on Private Capital Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.